Trends in serum total cholesterol and dietary fat intakes in New Zealand between 1989 and 2009

Australian and New Zealand Journal of Public Health

Volumn 40, Issue 3, 2016, Pages 263-269

  Miller, Jody C ^a   Smith, Claire ^a   Williams, Sheila M ^a   Mann, Jim I ^a   Brown, Rachel C ^a   Parnell, Winsome R ^a   Skeaff, C Murray ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

cholesterol; dietary fat; statins

Indexed keywords

CHOLESTEROL; FAT INTAKE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BLOOD; COMPARATIVE STUDY; FAT INTAKE; FEMALE; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; NEW ZEALAND; NUTRITION POLICY; REGRESSION ANALYSIS; SEX RATIO; SMOKING; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHOLESTEROL; DIETARY FATS; FEMALE; HEALTH SURVEYS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; NEW ZEALAND; NUTRITION POLICY; REGRESSION ANALYSIS; SEX DISTRIBUTION; SMOKING; YOUNG ADULT;

EID: 84963594814     PISSN: 13260200     EISSN: 17536405     Source Type: Journal    
DOI: 10.1111/1753-6405.12504     Document Type: Article

References (42)

1. World Health Organization. Global Status Report on Noncommunicable Diseases. Geneva (CHE): WHO Press; 2010.
2. Ministry of Health. Mortality and Demographic Data. Wellington (NZ): Government of New Zealand; 2011.
3. Mann J, Swinburn B, Beaglehole R, Mhurchu CN, Jackson R,. Diverging global trends in heart disease and diabetes: Implications for dietary guidelines. Lancet Diabetes Endocrinol. 2015: 3 (8): 584-5.
4. Unal B, Critchley JA, Capewell S,. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004; 109 (9): 1101-7.
5. Capewell S, Beaglehole R, Seddon M, McMurray J,. Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation. 2000; 102 (13): 1511-16.
6. Tobias M, Taylor R, Yeh LC, Huang K, Mann S, Sharpe N,. Did it fall or was it pushed? The contribution of trends in established risk factors to the decline in premature coronary heart disease mortality in New Zealand. Aust N Z J Public Health. 2008; 32 (2): 117-25.
7. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al., Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007; 370: 1829-39.
8. Cholesterol Treatment Trialists' Collaborators. Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet. 2005; 366 (9493): 1267-78.
9. Hooper L, Summerbell CD, Thompson R, Sills D, Roberts FG, Moore HJ, et al., Reduced or modified dietary fat for preventing cardiovascular disease (Cochrane Review). In: The Cochrane Database of Systematic Reviews; Issue 5, 2012. Chichester (UK): John Wiley; 2012.
10. Metcalf PA, Scragg RRK, Schaaf D, Dyall L, Black PN, Jackson R,. Trends in major cardiovascular risk factors in Auckland, New Zealand: 1982 to 2002-2003. N Z Med J. 2006; 119 (1245): U2308.
11. Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, et al., National, regional, and global trends in serum total cholesterol since 1980: Systematic analysis of health examination surveys and epidemiological studies with 321 countrym-years and 3.0 million participants. Lancet. 2011; 377 (9765): 578-86.
12. Clarke R, Frost C, Collins R, Appleby P, Peto R,. Dietary lipids and blood cholesterol: Quantitative meta-analysis of metabolic ward studies. BMJ. 1997; 314 (7074): 112-7.
13. Laugesen M, Swinburn B,. The New Zealand food supply and diet-trends 1961-95 and comparison with other OECD countries. N Z Med J. 2000; 113: 311-5.
14. Skeaff CM, Mann JI, McKenzie J, Wilson NC, Russell DG,. Declining levels of total serum cholesterol in adult New Zealanders. N Z Med J. 2001; 114 (1128): 131-4.
15. World Health Organization Food and Agriculture Organization. Diet, Nutrition and the Prevention of Chronic Disease. Geneva (CHE): WHO Press; 2003.
16. Metcalfe S, Moodie P,. More about cardiovascular disease and lipid management in New Zealand. N Z Med J. 2002; 115 (1163): U203.
17. Quigley R, Watts C,. Food Comes First: Methodologies for the National Nutrition Survey of New Zealand. Wellington (NZ): Ministry of Health; 1997.
18. Wilson N, Russell DG, Spears G, Herbison P,. Life in New Zealand Commission Report: Survey Protocol. Vol II. Wellington (NZ): Hillary Commission for Recreation and Sport; 1991.
19. University of Otago. Methodology Report for the 2008/09 New Zealand Adult Nutrition Survey [Internet]. Wellington (NZ): New Zealand Ministry of Health; 2011 [cited 2014 Jul 10]. Available from: http://www.moh.govt
20. Eliasson M, Janlert U, Jansson JH, Stegmayr B,. Time trends in population cholesterol levels 1986-2004: Influence of lipid-lowering drugs, obesity, smoking and educational level. The Northern Sweden MONICA Study. J Intern Med. 2006; 260 (6): 551-9.
21. Mindell J, Aresu M, Zaninotto P, Falaschetti E, Poulter N,. Improving lipid profiles and increasing use of lipid-lowering therapy in England: Results from a national cross-sectional survey-2006. Clin Endocrinol. 2011; 75: 621-7.
22. Kit BK, Carroll MD, Lacher DA, Sorlie PD, DeJesus JM, Ogden C,. Trends in serum lipids among US youths aged 6 to 19 years, 1988-2010. JAMA. 2012; 308 (6): 591-600.
23. Capewell S, Ford ES,. Why have total cholesterol levels declined in most developed countries? BMC Public Health. 2011; 11: 641.
24. Valsta LM, Tapanainen H, Sundvall J, Laatikainen T, Mannisto S, Pietinen P, et al., Explaining the 25-year decline of serum cholesterol by dietary changes and use of lipid-lowering medication in Finland. Public Health Nutr. 2010; 13 (6A): 932-8.
25. Kris-Etherton PM, Yu S,. Individual fatty acid effects on plasma lipids and lipoproteins: Human studies. Am J Clin Nutr. 1997; 65: 1628S-44S.
26. Vesper HW, Kuiper HC, Mirel LB, Johnson CL, Pirkle JL,. Levels of plasma trans-fatty acids in Non-Hispanic white adults in the United States in 2000 and 2009. JAMA. 2012; 307 (6): 562-3.
27. Food Standards Australia New Zealand. Intakes of Trans Fatty Acids in New Zealand and Australia. Review Report-2009 Assessment. Canberra (AUST): FSANZ; 2009.
28. Law M,. Dietary fat and adult diseases and the implications for childhood nutrition: An epidemiologic approach. Am J Clin Nutr. 2000; 72 Suppl: 1291-6.
29. Denke MA,. Review of human studies evaluating individual dietary responsiveness in patients with hypercholesterolemia. Am J Clin Nutr. 1995; 62: 471S-7S.
30. Ellis C, White H,. PHARMAC and the statin debacle. N Z Med J. 2006; 119 (1236): U2033.
31. Chisholm A, Mann J, Sutherland W, Williams S, Ball M,. Dietary management of patients with familial hypercholesterolaemia treated with simvastatin. Q J Med. 1992; 85 (307-308): 825-31.
32. Clifton PM, Noakes M, Nestel PJ,. Gender and diet interactions with simvastatin treatment. Atherosclerosis. 1994; 110 (1): 25-33.
33. Kelley GA, Kelley KS, Tran ZV,. Aerobic exercise and lipids and lipoproteins in women: A meta-analysis of randomized controlled trials. J Womens Health. 2004; 13 (10): 1148-64.
34. Kelley GA, Kelley KS,. Aerobic exercise and lipids and lipoproteins in men: A meta-analysis of randomized controlled trials. J Mens Health Gend. 2006; 3 (1): 61-70.
35. Ministry of Health. A Portrait of Health-Key Results of the 2006/07 New Zealand Health Survey 2008 [Internet]. Wellington (NZ): Government of New Zealand; 2011 [cited 2015 Apr 10]. Available from: http://www.moh.govt
36. Maeda K, Noguchi Y, Fukui T,. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: A meta-analysis. Prev Med. 2003; 37 (4): 283-90.
37. Mensink RP, Zock PL, Kester AD, Katan MB,. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003; 77 (5): 1146-55.
38. Institute of Medicine. Dietary Reference Intakes: Applications in Dietary Assessment. Washington (DC): National Academy Press; 2000.
39. Heitmann BL, Lissner L, Osler M,. Do we eat less fat, or just report so? Int J Obes Relat Metab Disord. 2000; 24 (4): 435-42.
40. Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, et al., Association of dietary, circulating, and supplement fatty acids with coronary risk: A systematic review and meta-analysis. Ann Intern Med. 2014; 160 (6): 398-406.
41. Hooper L, Martin N, Abdelhamid A, Davey Smith G,. Reduction in saturated fat intake for cardiovascular disease (Cochrane Review). In: The Cochrane Database Systematic Review; Issue 6, 2015. Chichester (UK): John Wiley; 2015.
42. Johansson I, Nilsson LM, Stegmayr B, Boman K, Hallmans G, Winkvist A,. Associations among 25-year trends in diet, cholesterol and BMI from 140,000 observations in men and women in Northern Sweden. Nutr J. 2012; 11: 40.